Rchr
J-GLOBAL ID:201801017060609088   Update date: Mar. 13, 2026

Tojo Arinobu

トウジョウ アリノブ | Tojo Arinobu
Affiliation and department:
Research field  (1): Clinical pharmacy
Research theme for competitive and other funds  (40):
  • 2020 - 2023 医療人工知能におけるブラックボックスの解明
  • 2018 - 2021 Integrative analysis of genetical mutations and heterogeneity based on stemness in breast cancer cells
  • 2015 - 2018 Elucidation of breast cancer tissue diversity by integration analysis of minimum unit omics
  • 2014 - 2018 Inhibitory co-receptors as new biomarkers for bone marrow transplantation
  • 2014 - 2016 Development of diagnostic system of mutations in breast cancer by using primary spheroid cells derived from patients
Show all
Papers (506):
  • Junya Makiyama, Nobuhiro Ohno, Koji Jimbo, Toyotaka Kawamata, Kazuaki Yokoyama, Takaaki Konuma, Seiko Kato, Tomonari Takemura, Ayumu Ito, Takashi Tanaka, et al. Outcomes of patients aged 70 years or younger with aggressive ATL at core hospitals for ATL treatment in Tokyo. International journal of hematology. 2025
  • Hidekazu Takahashi, Natsu Yamaguchi, Naoko Okayama, Mitsuaki Nishioka, M H Mahbub, Ryosuke Hase, Yutaka Suehiro, Takahiro Yamasaki, Satoshi Takahashi, Arinobu Tojo, et al. Relationship Between an Interleukin 6 SNP and Relapse After Allogeneic Bone Marrow Transplantation. Journal of clinical medicine. 2025. 14. 2
  • Koju Kamoi, Kaoru Uchimaru, Yasuhito Nannya, Arinobu Tojo, Toshiki Watanabe, Kyoko Ohno-Matsui. Sexual transmission of HTLV-1 resulting in uveitis with short-term latency and low proviral load. Journal of Medical Virology. 2024. 96. 10
  • Rintaro Ono, Kenichi Sakamoto, Ko Kudo, Aki Sato, Kazuko Kudo, Hisanori Fujino, Yuta Kawahara, Hiroya Hashimoto, Takehiko Doi, Ryu Yanagisawa, et al. Phase II study in children and adults under 40 years with newly diagnosed Langerhans cell histiocytosis: protocol for an LCH-19-MSMFB clinical trial in Japan. BMJ open. 2024. 14. 6. e084159
  • Makoto Yamagishi, Yuta Kuze, Seiichiro Kobayashi, Makoto Nakashima, Satoko Morishima, Toyotaka Kawamata, Junya Makiyama, Kako Suzuki, Masahide Seki, Kazumi Abe, et al. Mechanisms of action and resistance in histone methylation-targeted therapy. Nature. 2024
more...
MISC (307):
  • Huazi Zhang, Yasuto Takeuchi, Takahiko Murayama, Kazuhiro Ikeda, Satoshi Inoue, Kuniko Horie, Masao Yano, Masahiko Tanabe, Tetsuo Ota, Etsuo A. Susaki, et al. Analysis of the interaction between G-CSFR-expressing BCSCs and surrounding cells in the bone metastatic niche. CANCER SCIENCE. 2025. 116. 261-261
  • Yasuto Takeuchi, Huazi Zhang, Takahiko Murayama, Kazuhiro Ikeda, Satoshi Inoue, Kuniko Horie, Masao Yano, Masahiko Tanabe, Tetsuo Ota, Etsuo A. Susaki, et al. G-CSF-mediated interaction between CAFs and breast cancer stem cells is crucial for tumorigenesis and bone metastasis. CANCER SCIENCE. 2025. 116. 84-84
  • Yasuto Takeuchi, Takahiko Murayama, Risa Kashimura, Masao Yano, Masahiko Tanabe, Satoko Ishikawa, Tetsuo Ota, Keiichiro Tada, Eishu Hirata, Kazuhiro Ikeda, et al. GCSF secreted from CAFs initiates tumorigenesis and metastasis in triple negative breast cancer. CANCER SCIENCE. 2024. 115. 1780-1780
  • Yasuto Takeuchi, Natsuko Kimura, Takahiko Murayama, Yukino Machida, Daisuke Iejima, Tatsunori Nishimura, Yuming Wang, Mizuki Yamamoto, Naoki Itano, Junichiro Inoue, et al. FRS2b fashions a cytokine-rich inflammatory microenvironment that promotes breast cancer carcinogenesis. CANCER SCIENCE. 2022. 113. 994-994
  • Li Mengjiao, Tatsunori Nishimura, Daisuke Shiokawa, Shimamura Teppei, Asako Sasahara, Masao Yano, Satoko Ishikawa, Tetsuo Ota, Keiichiro Tada, Koji Okamoto, et al. Single-cell RNAseq identifies subpopulations of drug resistant cancer stem-like cells in patient-derived breast cancer. CANCER SCIENCE. 2022. 113. 1325-1325
more...
Professional career (1):
  • 医学博士
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page